1. 1) Spencer SP, Fragiadakis GK, Sonnenburg JL. Pursuing human-relevant gut microbiota-immune interactions. Immunity, 51, 225–239 (2019).
2. 2) Jia Q, Xie Y, Lu C, Zhang A, Lu Y, Lv S, Zhang J. Endocrine organs of cardiovascular diseases: gut microbiota. J. Cell. Mol. Med., 23, 2314–2323 (2019).
3. 3) Durack J, Lynch SV. The gut micribiome: Relationships with disease and opportunities for therapy. J. Exp. Med., 216, 20–40 (2019).
4. 4) Brial F, Le Lay A, Dumas ME, Gauguier D. Implication of gut microbiota metabolites in cardiovascular and metabolic disease. Cell. Mol. Life Sci., 75, 3977–3990 (2018).
5. 5) Cosola C, Rocchetti MT, Cupisti A, Gesualdo L. Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease. Pharmacol. Res., 130, 132–142 (2018).